IMI plc (LON:IMI – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,794.89 ($22.59) and traded as high as GBX 1,853 ($23.32). IMI shares last traded at GBX 1,824 ($22.95), with a volume of 331,712 shares changing hands.
IMI Stock Performance
The firm’s fifty day simple moving average is GBX 1,771.09 and its 200 day simple moving average is GBX 1,795.36. The company has a market capitalization of £4.71 billion, a PE ratio of 1,891.75, a price-to-earnings-growth ratio of 1.12 and a beta of 1.08. The company has a debt-to-equity ratio of 68.33, a current ratio of 1.36 and a quick ratio of 0.80.
Insider Transactions at IMI
In other news, insider Anne Thorburn bought 5,000 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of GBX 1,740 ($21.90) per share, with a total value of £87,000 ($109,475.27). Also, insider Jackie Callaway purchased 857 shares of the stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average cost of GBX 1,750 ($22.02) per share, for a total transaction of £14,997.50 ($18,871.90). Insiders have purchased 5,878 shares of company stock worth $10,237,592 over the last quarter. 1.52% of the stock is currently owned by insiders.
IMI Company Profile
IMI plc is a specialist engineering company operating in fluid and motion control markets. We combine our deep engineering knowledge with strong applications expertise to develop solutions for the most acute industry problems. We help our customers become safer, more sustainable and more productive. IMI employs around 10,000 people, has manufacturing facilities in 19 countries and operates a global service network.
Featured Stories
- Five stocks we like better than IMI
- What to Know About Investing in Penny Stocks
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- 3 Healthcare Dividend Stocks to Buy
- Top 3 ETFs to Hedge Against Inflation in 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for IMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMI and related companies with MarketBeat.com's FREE daily email newsletter.